Gilead Sciences Inc

GILD 
(NASDAQ) 
 
$ 65.55
Updated 09:06:13
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 3,449,718
High $ 66.96
Low $ 65.24
Open $ 66.93
ISIN
Prev close $ 66.98
# of shares 1,293.62M
Market cap 84,797M USD
Intraday

Market closed
Gilead Sciences Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  65.55 -3.0% Stock price decreasing -4.4% Stock price decreasing -1.8% Stock price decreasing -11.2% Stock price decreasing -17.4% Stock price decreasing
Powered by TradingView

News about Gilead Sciences Inc

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 75.14 -0.1% Stock price decreasing 5.1% Stock price increasing 9.6% Stock price increasing 14.4% Stock price increasing 27.4% Stock price increasing 3.9% Stock price increasing
 
Bristol-Myers Squibb Company 50.13 -3.0% Stock price decreasing 0.8% Stock price increasing -5.8% Stock price decreasing -17.2% Stock price decreasing -24.0% Stock price decreasing -3.6% Stock price decreasing
 
Merck & Company Inc (new) 79.83 0.0% Stock price increasing 5.3% Stock price increasing 6.7% Stock price increasing 15.6% Stock price increasing 46.3% Stock price increasing 4.5% Stock price increasing
 
Pfizer Inc 42.14 -0.6% Stock price decreasing -0.3% Stock price decreasing -2.2% Stock price decreasing 0.2% Stock price increasing 17.9% Stock price increasing -3.5% Stock price decreasing
 
Amgen Inc 185.50 -1.5% Stock price decreasing -8.2% Stock price decreasing -3.8% Stock price decreasing -6.2% Stock price decreasing 1.7% Stock price increasing -4.7% Stock price decreasing
 
Celgene Corporation 88.65 -2.2% Stock price decreasing 3.1% Stock price increasing 31.3% Stock price increasing -2.2% Stock price decreasing -5.5% Stock price decreasing 38.3% Stock price increasing
 
Novartis NAM SF 0,50 79.40 0.0% Stock price decreasing 2.0% Stock price increasing 3.9% Stock price increasing 9.5% Stock price increasing 14.5% Stock price increasing 6.7% Stock price increasing
 
Roche Hldg AG GEN 243.60 1.5% Stock price increasing 6.7% Stock price increasing 13.7% Stock price increasing 14.9% Stock price increasing 26.0% Stock price increasing 13.0% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,525.60 -3.5% Stock price decreasing 2.3% Stock price increasing -2.5% Stock price decreasing -5.5% Stock price decreasing 17.1% Stock price increasing 2.3% Stock price increasing
 
Sanofi 72.55 -3.6% Stock price decreasing -0.8% Stock price decreasing -7.3% Stock price decreasing -3.0% Stock price decreasing 11.8% Stock price increasing -4.1% Stock price decreasing
 
Biogen Inc 321.17 -3.5% Stock price decreasing -5.2% Stock price decreasing 1.8% Stock price increasing -6.9% Stock price decreasing 12.8% Stock price increasing 6.7% Stock price increasing

Company profile

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition boosted Gilead's exposure to cell therapy in oncology.

Peers

Instruments Last Change  
Abbott Labor.. 75.14 -0.5% Stock price decreasing
Bristol-Myer.. 50.13 -2.3% Stock price decreasing
Merck & Comp.. 79.83 0.5% Stock price increasing
Pfizer Inc 42.14 -0.1% Stock price decreasing
Amgen Inc 185.50 0.0% Stock price unchanged
Celgene Corp.. 88.65 0.0% Stock price unchanged
93,97,72,54,60,49,42,21,48,42
Novartis NAM.. 79.40 -0.5% Stock price decreasing
Roche Hldg A.. 243.60 0.0% Stock price increasing
Glaxosmithkl.. 1,525.60 -0.8% Stock price decreasing
Sanofi 72.55 -0.8% Stock price decreasing
Biogen Inc 321.17 0.0% Stock price unchanged

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 February 2019 09:21:38
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20190215.1 - EUROWEB4 - 2019-02-22 10:21:38 - 2019-02-22 09:21:38 - 1000 - Website: OKAY